(Nature) Katherine Sharpe–ADHD Medication: is this a smart-pill oversell?

For most people with ADHD, these medications ”” typically formulations of methylphenidate or amphetamine ”” quickly calm them down and increase their ability to concentrate. Although these behavioural changes make the drugs useful, a growing body of evidence suggests that the benefits mainly stop there. Studies indicate that the improvements seen with medication do not translate into better academic achievement or even social adjustment in the long term: people who were medicated as children show no improvements in antisocial behaviour, substance abuse or arrest rates later in life, for example. And one recent study suggested that the medications could even harm some children1.

After decades of study, it has become clear that the drugs are not as transformative as their marketers would have parents believe. “I don’t know of any evidence that’s consistent that shows that there’s any long-term benefit of taking the medication,” says James Swanson, a psychologist at the University of California, Irvine.

Now researchers are trying to understand why. The answer could lie in sub-optimal use of the drugs, or failure to address other factors that affect performance, such as learning disabilities. Or it could be that people place too much hope on a simple fix for a complex problem. “What we expect medication to do may be unrealistic,” says Lily Hechtman, a psychiatrist at McGill University in Montreal.

Read it all.

print

Posted in * Culture-Watch, * Economics, Politics, Children, Consumer/consumer spending, Corporations/Corporate Life, Economy, Education, Ethics / Moral Theology, Health & Medicine, Media, Psychology, Science & Technology, Theology